US Pharma MarketingThe post NET Recovery wins FDA breakthrough tag for psychostimulant addiction device appeared first on Medical Device Network.
NET Recovery wins FDA breakthrough tag for psychostimulant addiction device
NET Recovery’s device applies neurostimulation to quell cravings in individuals with stimulant use disorder. NET Recovery’s device applies neurostimulation to quell cravings in individuals with stimulant use disorder. A GlobalData report forecasts that the global neurological devices market will reach a valuation of $20.9bn by 2033. Credit: Tada Images/Shutterstock.com Unlock FREE Access to Premium Content Discover exclusive forecasts, analyst insights, and in-depth analysis across the medical device and healthcare technology industry. With a free Medical Device Network profile, you can: Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise. The leading site for news…
NET Recovery’s device applies neurostimulation to quell cravings in individuals with stimulant use disorder.
Source: Medical Device Network